EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Respiratory syncytial virus infection in adults

Hannah H Nam, Michael G Ison

BMJ · 10.09.2019 · l5021

DOI: 10.1136/bmj.l5021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BMJ, online erschienen am 10.09.2019. Verfasst von Hannah H Nam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: Global Burden of Disease. Die Arbeit wurde bisher 309-mal zitiert (Crossref) und nennt 189 Literaturangaben. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae family, Orthopneumovirus genus. It is a negative sense, single stranded RNA virus that results in epidemics of respiratory infections that typically peak in the winter in temperate climates and during the rainy season in tropical climates. Generally, one of the two genotypes (A and B) predominates in a single season, alternating annually, although regional variation occurs. RSV is a cause of disease and death in children, older people, and immunocompromised patients, and its clinical effect on adults admitted to hospital is clarified with expanded use of multiplex molecular assays. Among adults, RSV produces a wide range of clinical symptoms including upper respiratory tract infections, severe lower respiratory tract infections, and exacerbations of underlying disease. Here we discuss the latest evidence on the burden of RSV related disease in adults, especially in those with immunocompromise or other comorbidities. We review current therapeutic and prevention options, as well as those in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global Burden of DiseaseAdultAntiviral AgentsEpidemicsGenotypeHumansImmunocompromised HostImmunoglobulins, IntravenousRespiratory Syncytial Virus InfectionsRespiratory Syncytial VirusesRespiratory Tract InfectionsRibavirinSeasons

Substanzen

Antiviral AgentsImmunoglobulins, IntravenousRibavirin

Autor:innen und Institutionen

  • Division of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
  • Division of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA mgison@northwestern.edu.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Nam, H. H., & Ison, M. G. (2019). Respiratory syncytial virus infection in adults. BMJ, l5021. https://doi.org/10.1136/bmj.l5021

Vancouver

Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019:l5021. doi:10.1136/bmj.l5021

BibTeX
@article{Nam2019,
  author = {Nam, Hannah H and Ison, Michael G},
  title = {Respiratory syncytial virus infection in adults},
  journal = {BMJ},
  year = {2019},
  pages = {l5021},
  doi = {10.1136/bmj.l5021}
}
Kostenlos starten →